APA (7th ed.) Citation

G, P., T, D., GA, K., WR, G., M, B., R, K., . . . P, B. (2024). Biologically defined neuronal synuclein disease as a tool to advance drug development. NPJ Parkinson's disease, 10(1), 235. https://doi.org/10.1038/s41531-024-00845-5

Chicago Style (17th ed.) Citation

G, Pagano, et al. "Biologically Defined Neuronal Synuclein Disease as a Tool to Advance Drug Development." NPJ Parkinson's Disease 10, no. 1 (2024): 235. https://doi.org/10.1038/s41531-024-00845-5.

MLA (9th ed.) Citation

G, Pagano, et al. "Biologically Defined Neuronal Synuclein Disease as a Tool to Advance Drug Development." NPJ Parkinson's Disease, vol. 10, no. 1, 2024, p. 235, https://doi.org/10.1038/s41531-024-00845-5.